Latest data from January 14, 2022
Number of Health Center respondents = 28 (80% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 27,763 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 60.20% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 9,728 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 56.78% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 37.98% | 41.84% |
| White, Hispanic/Latino Patients | 7.81% | 7.61% |
| Black/African American, Non-Hispanic/Latino Patients | 44.96% | 42.99% |
| Black/African American, Hispanic/Latino Patients | 0.28% | 0.28% |
| Asian Patients3 | 1.04% | 0.95% |
| American Indian/Alaska Native Patients3 | 0.35% | 0.25% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.10% | 0.05% |
| Patients with More Than One Race3 | 1.75% | 1.71% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.15% | 1.14% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.31% | 0.88% |
| Unreported/Refused to Report Race and Ethnicity | 2.29% | 2.31% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,087 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 79.28% |
| COVID-19 Immunization Series Completed | 826 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 84.06% |
| COVID-19 Immunization Series Additional | 2,360 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 71.01% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 20.06% | 15.01% | 27.88% |
| White, Hispanic/Latino Patients | 16.74% | 14.16% | 13.60% |
| Black/African American, Non-Hispanic/Latino Patients | 51.70% | 55.81% | 41.65% |
| Black/African American, Hispanic/Latino Patients | 1.10% | 1.33% | 0.85% |
| Asian Patients3 | 0.92% | 2.06% | 2.42% |
| American Indian/Alaska Native Patients3 | 0.46% | 1.33% | 8.05% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.09% | 0.24% | 0.08% |
| Patients with More Than One Race3 | 1.10% | 1.69% | 0.47% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.60% | 2.54% | 1.19% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.37% | 0.61% | 0.59% |
| Unreported/Refused to Report Race and Ethnicity | 2.85% | 5.21% | 3.22% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 17.86% |
| 1 to 24 Hours | 21.43% |
| More Than 24 Hours | 60.71% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 0.00% |
| Staffing to administer the vaccine | 50.00% |
| Vaccine confidence | 32.14% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 3.57% |
| None | 25.00% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 17.86% |
| Average Percent of Health Center Visits Conducted Virtually | 9.64% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 32.14% |
| Number of Mobile Van Sites | 4 |
| Number of Pop-up Clinics | 2 |
| Number of School-Based Vaccination Sites | 3 |
| Number of Family Vaccination Clinics | 11 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 7.14% |
| Refer patients to another organization that provides monoclonal antibody therapies | 57.14% |
| None | 35.71% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 7.14% |
| Patient awareness/education | 7.14% |
| Staffing capacity | 25.00% |
| Therapy administration/onsite logistics | 14.29% |
| Other | 3.57% |
| None | 64.29% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 5 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 23,061 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provide to Existing Health Center Patients | 80.00% |
| Provide to General Public Who Came to the Health Center | 80.00% |
| Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 0.00% |
| Provide at Other Community Events | 60.00% |
| Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) | 40.00% |
| Other | 40.00% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 1 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 | 0.00% |
Oral Antiviral Medication Distribution by Race and Ethnicity5
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 66.67% |
| White, Hispanic/Latino Patients | 0.00% |
| Black/African American, Non-Hispanic/Latino Patients | 0.00% |
| Black/African American, Hispanic/Latino Patients | 0.00% |
| Asian Patients3 | 0.00% |
| American Indian/Alaska Native Patients3 | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
| Patients with More Than One Race3 | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 0.00% |
Oral Antiviral Medication Distribution by Special/Vulnerable Population5
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 0.00% |
| Patients Experiencing Homelessness | 0.00% |
| Patients Who Are Residents of Public Housing | 0.00% |
| Patients with Limited English Proficiency | 0.00% |
| Children Under 18 Years of Age | 0.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.
